Skip to content
QB
Company

Updated:

Q BioMed Inc.

Q BioMed Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001596062, and its reported industry is...

Overview

Q BioMed Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001596062, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-05-26, it reported annual revenue of USD 284,352; net income of USD -2,052,093; total assets of USD 3,515,517 for the fiscal period ended 2022-11-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Q BioMed Inc.
Former names in filing history
ISMO Tech Solutions, Inc. (2014-01-13 to 2015-07-15)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
New York, NY, United States
Incorporated in
NV
Fiscal year end
November 30
SEC CIK
0001596062

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2022USD$284,352-$2.1M$3.5M—$1.9M
FY2021USD$195,597-$8.2M$809,480—-$4.3M
FY2020USD$30,000-$13.5M$623,484$177,145-$6.2M
FY2019USD—-$10.3M$640,298$172,636-$4.1M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
10-K10-K
8-KFORM 8-K
10-Q10-Q
10-Q10-Q
8-KFORM 8-K
10-Q10-Q
10-K10-K
8-KFORM 8-K
10-QFORM 10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Q BioMed Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Q BioMed Inc. | New York Company | Altss